Bria, E., Milella, M., Cuppone, F., Novello, S., Ceribelli, A., Vaccaro, V., . . . Giannarelli, D. (2011). Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: A meta-analysis. Oxford University Press.
Chicago Stili AlıntıBria, E., et al. Outcome of Advanced NSCLC Patients Harboring Sensitizing EGFR Mutations Randomized to EGFR Tyrosine Kinase Inhibitors or Chemotherapy As First-line Treatment: A Meta-analysis. Oxford University Press, 2011.
MLA AlıntıBria, E., et al. Outcome of Advanced NSCLC Patients Harboring Sensitizing EGFR Mutations Randomized to EGFR Tyrosine Kinase Inhibitors or Chemotherapy As First-line Treatment: A Meta-analysis. Oxford University Press, 2011.